BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31942259)

  • 1. A multiomics comparison between endometrial cancer and serous ovarian cancer.
    Zhong H; Chen H; Qiu H; Huang C; Wu Z
    PeerJ; 2020; 8():e8347. PubMed ID: 31942259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.
    Sung CO; Song IH; Sohn I
    Gynecol Oncol; 2014 Feb; 132(2):343-50. PubMed ID: 24321399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of chemo-response in serous ovarian cancer.
    Gonzalez Bosquet J; Newtson AM; Chung RK; Thiel KW; Ginader T; Goodheart MJ; Leslie KK; Smith BJ
    Mol Cancer; 2016 Oct; 15(1):66. PubMed ID: 27756408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular pathology of endometrial carcinoma - a review].
    Kajo K; Vallová M; Biró C; Bognár G; Macháleková K; Závodná K; Galbavý Š; Žúbor P
    Cesk Patol; 2015; 51(2):65-73. PubMed ID: 25970717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
    Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
    Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
    Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer.
    Tian W; Shan B; Zhang Y; Ren Y; Liang S; Zhao J; Zhao Z; Wang G; Zhao X; Peng D; Bi R; Cai S; Bai Y; Wang H
    Cancer Med; 2020 Mar; 9(6):2190-2200. PubMed ID: 31991061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro.
    Filipe A; Katopodis P; Chudasama D; Kerslake R; Jeyaneethi J; Anikin V; Silva E; Kyrou I; Randeva HS; Sisu C; Hall M; Karteris E
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.
    Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H
    Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic landscape of endometrial clear cell carcinomas.
    DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
    J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
    Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
    Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.
    Kolbe DL; DeLoia JA; Porter-Gill P; Strange M; Petrykowska HM; Guirguis A; Krivak TC; Brody LC; Elnitski L
    PLoS One; 2012; 7(3):e32941. PubMed ID: 22403726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
    Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Xu X; Lu F; Fang C; Liu S
    J Healthc Eng; 2022; 2022():7832618. PubMed ID: 35242299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.